Role of Coronary CTA on Lipid Management and Risk Factors Control in an Asymptomatic Chinese Population
Recruiting
N/A
Interventional Study
Statin
Cardiovascular Risk Factors
Primary Prevention
Adherence, Medication
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 40 – 69
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 3,400 (estimated)
- Sponsor
- Zhang longjiang,MD · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The primary objective of this study is to determine whether coronary computed tomography angiography (CCTA) -based coronary heart disease(CHD) prevention strategy improves lipid-lowering treatment and cardiovascular risk factor control compared with traditional CHD prevention strategy, guided by a cardiovascular risk score.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Nanjing residents who have no plans to leave in the next 5 years
2. Aged from 40 to 69 years
3. Free of any known clinically cardiovascular disease Able to comprehend and sign an informed consent form
Exclusion Criteria:
1. Serious liver dysfunction, defined as AST or ALT \…
Contacts